The Research and Development team at Aptose Biosciences focuses on discovering, designing, and advancing novel targeted therapies for hematologic malignancies. This team combines expertise in chemistry, regulatory affairs, clinical sciences, and translational research to develop first-in-class drugs, ensuring they meet rigorous standards for clinical trials and regulatory approval.
View all